financetom
Business
financetom
/
Business
/
What's Going On With ChargePoint Stock On Wednesday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With ChargePoint Stock On Wednesday?
May 26, 2025 11:49 AM

ChargePoint Holdings, Inc. ( CHPT ) shares are trading higher on Wednesday after the firm revealed a strategic collaboration with Eaton, a leading power management firm.

The partnership aims to speed up the rollout of electric vehicle charging infrastructure across North America and Europe by offering integrated solutions that combine EV chargers, power systems, and engineering services. The effort is designed to simplify project execution while minimizing costs for customers.

Under the alliance, ChargePoint ( CHPT ) and Eaton will collaborate to create end-to-end electrification solutions, including advancements in bidirectional power flow and vehicle-to-everything (V2X) technology. This will enable EVs to operate as mobile energy hubs, powering homes, commercial buildings, and more.

Also Read: EVgo Vs. ChargePoint ( CHPT ): Tariffs, Technicals, And The Road To Profitability

By integrating EV chargers and supporting infrastructure, the companies intend to make it easier for organizations to electrify their fleets and facilities.

The collaboration positions ChargePoint ( CHPT ) to deliver a full-service EV ecosystem, bridging gaps between vehicles, charging networks, and energy grids through its cloud-based software platform.

According to Benzinga Pro, CHPT stock has lost over 57% in the past year. Investors can gain exposure to the stock via WisdomTree Trust WisdomTree Battery Value Chain and Innovation Fund .

“ChargePoint’s partnership with Eaton will deliver innovation that addresses the biggest barriers to electrified transportation,” said Rick Wilmer, ChargePoint’s CEO.

Paul Ryan, General Manager of Energy Transition at Eaton, said the customers habitually turn to Eaton for solutions to their most complex power management challenges, and this partnership is set to directly address that need for vehicle charging, bringing together trusted power distribution and EV charging solutions to simplify electrification at scale.

Price Action: CHPT shares are trading higher by 2.56% to $0.7231 at last Wednesday.

Read Next:

Plug Power Chases Growth Beyond US Tax Credit Hurdles

Image by YuniqueB via Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Street Color: Schlumberger, Canada's Competition Bureau Reach Consent Agreement on ChampionX Takeover
--Street Color: Schlumberger, Canada's Competition Bureau Reach Consent Agreement on ChampionX Takeover
Jul 16, 2025
09:39 AM EDT, 07/16/2025 (MT Newswires) -- Price: 35.12, Change: +0.04, Percent Change: +0.11 ...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Oncolytics Biotech Says Pelareorep Data Showed Effectiveness Across Multiple Tumor Types
Oncolytics Biotech Says Pelareorep Data Showed Effectiveness Across Multiple Tumor Types
Jul 16, 2025
09:43 AM EDT, 07/16/2025 (MT Newswires) -- Oncolytics Biotech ( ONCY ) said Wednesday that translational data for its intravenously delivered immunotherapeutic agent, pelareorep, showed effectiveness of the therapy across multiple tumor types. The data confirmed viral replication, interferon signaling, and a surge in tumor-infiltrating lymphocytes after pelareorep treatment, the company said. Oncolytics Biotech ( ONCY ) added that the...
Citius Oncology Prices Public Offering at $1.32 a Share
Citius Oncology Prices Public Offering at $1.32 a Share
Jul 16, 2025
09:45 AM EDT, 07/16/2025 (MT Newswires) -- Citius Oncology ( CTOR ) said Wednesday that it priced its reasonable best-efforts public offering of about 6.8 million common shares and warrants to purchase common shares at $1.32 per share, for total proceeds of about $9 million. The company said the warrants are immediately exercisable for $1.32 per share and will expire...
Copyright 2023-2026 - www.financetom.com All Rights Reserved